BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18681186)

  • 1. Clinical management of drug addicts infected with human immunodeficiency virus and hepatitis C virus.
    Khalsa JH; Vocci F
    J Addict Dis; 2008; 27(2):1-10. PubMed ID: 18681186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for HIV and hepatitis C virus infections in recreational drug users.
    Khalsa JH; Elkashef A
    Clin Infect Dis; 2010 Jun; 50(11):1505-11. PubMed ID: 20415569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
    Verucchi G; Calza L; Manfredi R; Chiodo F
    Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus and hepatitis C virus co-infection.
    Vlahakis SR
    J Med Liban; 2006; 54(2):106-10. PubMed ID: 17087002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric problems in patients infected with hepatitis C before and during antiviral treatment with interferon-alpha: a review.
    Quelhas R; Lopes A
    J Psychiatr Pract; 2009 Jul; 15(4):262-81. PubMed ID: 19625882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic interventions for HIV infection and chronic viral hepatitis.
    Cooper CL
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S69-72. PubMed ID: 16265617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
    Neuman MG; Monteiro M; Rehm J
    Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A golden opportunity: the treatment of hepatitis C in HIV-infected inmates.
    McGovern B
    J Addict Dis; 2008; 27(2):69-73. PubMed ID: 18681193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
    Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of HCV-HIV patients].
    Pol S; Cacoub P; Pialoux G; Benhamou Y; Halfon P; Rosenthal E; Perronne C
    Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S7-12. PubMed ID: 17965629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues.
    Celentano DD; Lucas G
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S318-23. PubMed ID: 18190306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and therapy of chronic hepatitis C virus infection in HIV-infected individuals.
    Mauss S
    J HIV Ther; 2007 Mar; 12(1):11-7. PubMed ID: 17589391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?
    Schaefer M; Heinz A; Backmund M
    Addiction; 2004 Sep; 99(9):1167-75. PubMed ID: 15317637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of HIV and HCV infections among injection drug users in northeast India.
    Mahanta J; Borkakoty B; Das HK; Chelleng PK
    AIDS Care; 2009 Nov; 21(11):1420-4. PubMed ID: 20024719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection.
    Dore GJ; Thomas DL
    Semin Liver Dis; 2005 Feb; 25(1):18-32. PubMed ID: 15731995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HIV and HCV infections--clinical implications].
    Pawłowska M; Halota W; Grabczewska E
    Przegl Epidemiol; 2004; 58 Suppl 1():71-5. PubMed ID: 15807161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies.
    Tedaldi EM
    J Addict Dis; 2008; 27(2):83-91. PubMed ID: 18681195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.